Live feed01:15:00·1034dPRReleasevia QuantisnowRoyalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (nadofaragene firadenovec-vncg)ByQuantisnow·Wall Street's wire, on your screen.RPRX· Royalty Pharma plcHealth Care
